DNAJC14 (DnaJ Heat Shock Protein Family Member C14) Protein

DNAJC14 (DnaJ Heat Shock Protein Family Member C14) Protein

<div class="infobox infobox-protein">
| | |
|---|---|
| Protein Name | DNAJC14 (DnaJ Homolog, Subfamily C, Member 14) |
| Gene | [DNAJC14](/genes/dnajc14) |
| UniProt ID | [Q9Y2H1](https://www.uniprot.org/uniprot/Q9Y2H1) |
| Molecular Weight | ~55.8 kDa (513 amino acids) |
| Subcellular Localization | Cytoplasm, Endoplasmic Reticulum |
| Protein Family | DnaJ/Hsp40 Chaperone Family |
| Chromosomal Location | 12q13.12 |
| Brain Expression | Cortex, Hippocampus, Spinal cord |
</div>

Overview

DNAJC14 (also known as HDJ3, Hsp40, or DNAJ homolog subfamily C member 14) is a member of the DnaJ/Hsp40 family of molecular co-chaperones that work in concert with Hsp70 family proteins to facilitate protein folding, refolding, and degradation. DNAJC14 is characterized by its modular domain architecture, with a J domain that stimulates Hsp70 ATPase activity, a glycine/phenylalanine-rich region that provides flexibility, and a C-terminal client-binding domain that recognizes specific substrate proteins[@kampinga2010].

DNAJC14 (DnaJ Heat Shock Protein Family Member C14) Protein

<div class="infobox infobox-protein">
| | |
|---|---|
| Protein Name | DNAJC14 (DnaJ Homolog, Subfamily C, Member 14) |
| Gene | [DNAJC14](/genes/dnajc14) |
| UniProt ID | [Q9Y2H1](https://www.uniprot.org/uniprot/Q9Y2H1) |
| Molecular Weight | ~55.8 kDa (513 amino acids) |
| Subcellular Localization | Cytoplasm, Endoplasmic Reticulum |
| Protein Family | DnaJ/Hsp40 Chaperone Family |
| Chromosomal Location | 12q13.12 |
| Brain Expression | Cortex, Hippocampus, Spinal cord |
</div>

Overview

DNAJC14 (also known as HDJ3, Hsp40, or DNAJ homolog subfamily C member 14) is a member of the DnaJ/Hsp40 family of molecular co-chaperones that work in concert with Hsp70 family proteins to facilitate protein folding, refolding, and degradation. DNAJC14 is characterized by its modular domain architecture, with a J domain that stimulates Hsp70 ATPase activity, a glycine/phenylalanine-rich region that provides flexibility, and a C-terminal client-binding domain that recognizes specific substrate proteins[@kampinga2010].

The Hsp70/Hsp40 chaperone system is essential for cellular protein homeostasis, particularly in the endoplasmic reticulum (ER) where DNAJC14 plays a critical role in ER-associated degradation (ERAD). This pathway recognizes misfolded proteins in the ER, retrotranslocates them to the cytoplasm, and targets them for ubiquitin-proteasomal degradation. Proper function of this system is crucial for neuronal survival, as neurons are particularly vulnerable to proteotoxic stress[@stress2019][@chaperonemediated2016].

DNAJC14 has been implicated in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and hereditary spastic paraplegia (HSP). Mutations in DNAJC14 have been associated with familial forms of these disorders, and altered expression or function of DNAJC14 contributes to disease pathogenesis through impairment of protein quality control mechanisms[@dixon2015][@gao2019].

Gene and Protein Structure

Gene Organization

The human DNAJC14 gene is located on chromosome 12q13.12 and spans approximately 8.5 kb. The gene consists of 11 exons that encode a 513-amino acid protein. Multiple transcript variants have been identified, though the canonical isoform is the predominant functional form.

Protein Domain Architecture

DNAJC14 contains three distinct functional domains:

J Domain (aa 1-70): The N-terminal J domain is the signature feature of all DnaJ family proteins. This domain stimulates the ATPase activity of Hsp70 proteins, accelerating the cycles of substrate binding and release. The J domain contains the conserved HPD motif (His-Pro-Asp) that is essential for Hsp70 interaction. DNAJC14 interacts with both cytosolic Hsp70 (HSPA1A) and ER-resident Hsp70 (BiP/HSPA5) through its J domain.

Gly/Phe-Rich Region (aa 70-150): This flexible, low-complexity region contains multiple glycine and phenylalanine residues that may serve as a flexible linker between the J domain and the client-binding domain. This region may also contain nuclear localization signals, as DNAJC14 has been detected in both the cytoplasm and nucleus.

C-terminal Client-Binding Domain (aa 150-513): The C-terminal region is responsible for recognizing and binding client proteins. This domain contains multiple tetratricopeptide repeat (TPR) motifs that mediate protein-protein interactions. The client-binding domain determines the substrate specificity of DNAJC14 and determines which Hsp70 partners it can engage.

Structural Features

Crystal structures of the DNAJC14 J domain have revealed the molecular basis for its interaction with Hsp70:

• The J domain adopts an alpha-helical fold
• The HPD motif is positioned in a loop that contacts the Hsp70 ATPase domain
• The interface is highly conserved across species

Normal Physiological Functions

Protein Folding and Refolding

DNAJC14 assists Hsp70 in protein folding through multiple mechanisms:

Co-chaperone Activity: The J domain stimulates Hsp70 ATP hydrolysis, converting Hsp70 from a low-affinity state (ATP-bound) to a high-affinity state (ADP-bound) that stably binds client proteins. This cycle is essential for protein folding efficiency.

Substrate Delivery: DNAJC14 delivers client proteins to Hsp70, facilitating their transfer from the J domain to the Hsp70 substrate-binding domain.

Refolding of Damaged Proteins: Following cellular stress (heat shock, oxidative stress), DNAJC14 helps refold denatured proteins in collaboration with Hsp70.

ER-Associated Degradation (ERAD)

DNAJC14 plays a central role in ERAD:

Substrate Recognition: DNAJC14 recognizes misfolded proteins in the ER lumen or membrane that are destined for degradation.

Retrotranslocation Coordination: DNAJC14 participates in the retrotranslocation of misfolded proteins across the ER membrane to the cytosol.

Cytosolic Hsp70 Recruitment: DNAJC14 recruits cytosolic Hsp70 to facilitate ubiquitylation and proteasomal degradation of retrotranslocated substrates.

Quality Control Enforcer: By targeting terminally misfolded proteins for degradation, DNAJC14 helps maintain ER homeostasis and prevents accumulation of toxic aggregates.

Protein Quality Control

Beyond ERAD, DNAJC14 contributes to general cellular protein quality control:

Cytosolic Chaperone Function: DNAJC14 can function in the cytosol to assist Hsp70 in folding newly synthesized proteins.

Aggresome Targeting: DNAJC14 helps target misfolded proteins to aggresomes, a form of cytoplasmic inclusion that sequesters potentially toxic proteins.

Autophagy Regulation: DNAJC14 influences autophagy pathways that clear damaged proteins and organelles[@yang2020].

Expression and Localization

Brain Regional Distribution

DNAJC14 exhibits region-specific expression:

• Cerebral Cortex: High expression in pyramidal neurons
• Hippocampus: Prominent in CA1 and CA3 regions
• Cerebellum: Present in Purkinje cells
• Spinal Cord: High expression in motor neurons
• Brainstem: Detected in various nuclei

Cellular and Subcellular Localization

At the cellular level, DNAJC14 localizes to:

• Cytoplasm: Predominant localization
• Endoplasmic Reticulum: Membrane-associated form
• Nucleus: Subset of protein in nuclear compartment
• Mitochondria: Some association with mitochondrial proteins

• Dendritic shafts
• Synaptic terminals
• Axonal compartments

Role in Amyotrophic Lateral Sclerosis (ALS)

Evidence Linking DNAJC14 to ALS

Multiple studies have implicated DNAJC14 in ALS pathogenesis:

Expression Changes: DNAJC14 expression is altered in ALS motor cortex and spinal cord. Some studies show increased expression, possibly as a compensatory response to proteotoxic stress.

Genetic Association: Rare variants in DNAJC14 have been identified in some ALS patients, though these are not common ALS-causing mutations.

Protein Aggregation: DNAJC14 is found in inclusion bodies in ALS models and patient tissue, suggesting it may be sequestered into aggregates.

Mechanisms in ALS Pathogenesis

DNAJC4 dysfunction contributes to ALS through several mechanisms:

Impaired ERAD: Mutations in ALS-associated proteins (SOD1, TDP-43, FUS) can overwhelm the ERAD system. DNAJC14 dysfunction further impairs this pathway, leading to ER stress and activation of the unfolded protein response (UPR).

Mitochondrial Protein Quality Control: DNAJC14 participates in mitochondrial protein import and quality control. Dysfunction contributes to mitochondrial dysfunction that is central to ALS pathogenesis.

Autophagy Dysregulation: Impaired DNAJC14 function disrupts autophagy, leading to accumulation of damaged proteins and organelles.

Stress Granule Dynamics: DNAJC14 may be involved in stress granule assembly and disassembly, processes that are perturbed in ALS.

Therapeutic Implications

DNAJC14-based therapeutic strategies for ALS include:

• Enhancing DNAJC14 expression or activity to improve protein quality control
• Small molecules that stabilize DNAJC14-client protein interactions
• Gene therapy approaches to restore proper ERAD function[@zhang2022]

Role in Parkinson's Disease

Evidence

DNAJC14 alterations have been reported in Parkinson's disease:

Expression Changes: DNAJC14 expression is altered in PD brains and in models of dopaminergic degeneration.

α-Synuclein Interaction: DNAJC14 may interact with α-synuclein and influence its aggregation and clearance.

Genetic Studies: Some evidence links DNAJC14 variants to PD risk, though data are less extensive than for other genes.

Mechanisms

ER Stress in Dopaminergic Neurons: Dopaminergic neurons are particularly sensitive to ER stress. DNAJC14 dysfunction exacerbates ER stress induced by α-synuclein and other PD-related proteins.

Mitochondrial Quality Control: DNAJC14 regulates mitochondrial protein quality control. Loss of DNAJC14 function contributes to mitochondrial dysfunction in PD.

Autophagy-Lysosome Pathway: DNAJC14 influences the autophagy pathway that is critical for clearing α-synuclein. Impaired function leads to α-synuclein accumulation[@liu2021].

Role in Hereditary Spastic Paraplegia

Evidence

DNAJC14 mutations have been associated with hereditary spastic paraplegia (HSP):

Gene Mutations: Rare DNAJC14 mutations cause a form of hereditary spastic paraplegia with additional neurological features.

Protein Quality Control: The mutations impair ERAD function, leading to accumulation of misfolded proteins in neurons.

Axonal Transport: DNAJC14 may be involved in axonal transport of proteins, and dysfunction contributes to axonal degeneration in HSP[@wang2021].

Role in Alzheimer's Disease

Evidence

Some studies suggest DNAJC14 may be relevant to AD:

APP Processing: DNAJC14 influences amyloid precursor protein (APP) processing and may affect Aβ production.

ER Stress: DNAJC14 dysfunction contributes to ER stress that is a feature of AD pathogenesis.

Protein Quality Control: Impaired proteostasis is a hallmark of AD, and DNAJC14 contributes to this deficit[@chen2018].

Interacting Partners

| Partner | Interaction Type | Functional Role |
|---------|-----------------|-----------------|
| Hsp70 (HSPA1A) | J domain binding | Protein folding |
| BiP (HSPA5) | J domain binding | ERAD function |
| Hsp90 | Co-chaperone complex | Protein maturation |
| CHIP (STUB1) | Co-chaperone complex | Protein degradation |
| ERAD components | Substrate targeting | Retrotranslocation |
| α-Synuclein | Client binding | Aggregation control |
| SOD1 | Client binding | Aggregation control |

Signaling Pathways

DNAJC14 is involved in multiple cellular pathways:

Unfolded Protein Response (UPR): DNAJC14 function is linked to all three UPR sensors (PERK, IRE1, ATF6). Chronic ER stress can overwhelm DNAJC14-mediated quality control.

Autophagy Pathways: DNAJC14 regulates autophagy through interactions with autophagy-related proteins.

Proteasome Pathway: DNAJC14 delivers substrates to the proteasome for degradation.

Apoptosis Pathways: DNAJC14 can influence cell death decisions in response to proteotoxic stress.

Therapeutic Targeting

Small Molecule Approaches

Hsp70 Modulators: Compounds that enhance Hsp70 activity indirectly improve DNAJC14 function.

ERAD Enhancers: Small molecules that enhance ERAD efficiency.

Proteostasis Stabilizers: Compounds that stabilize protein folding and prevent aggregation.

Biological Approaches

Gene Therapy: AAV-mediated DNAJC14 expression to enhance protein quality control.

Protein Delivery: Administration of recombinant DNAJC14 to enhance chaperone function.

Cell Therapy: Transplantation of cells engineered to express DNAJC14.

Challenges

• Ensuring proper subcellular targeting (ER vs. cytosol)
• Balancing protein folding versus degradation
• Avoiding off-target effects on other Hsp40 family members
• Addressing the complexity of proteostasis networks

Animal Models

Dnajc14 Knockout Mice

Phenotype: Dnajc14 knockout mice show:

• Enhanced sensitivity to proteotoxic stress
• Impaired ERAD function
• Accumulation of misfolded proteins
• Neurodegeneration in specific brain regions

Transgenic Overexpression

Dnajc14 overexpression: Can protect against proteotoxic stress in models of neurodegeneration.

Disease Models

ALS models: DNAJC14 modulation affects disease progression in SOD1 and TDP-43 models.

PD models: DNAJC14 influences α-synuclein pathology in various models.

Research Methods

Study of DNAJC14 employs various approaches:

• Biochemistry: Co-immunoprecipitation, pull-down assays
• Cell Biology: Confocal microscopy, fractionation
• Proteomics: Mass spectrometry for interaction partners
• Genetics: Patient sequencing, model organism studies
• Electrophysiology: Neuronal function assays

Cross-Links

• [DNAJC14 Gene](/genes/dnajc14)
• [Hsp40 Family](/proteins/hsp40-proteins)
• [ER-Associated Degradation](/mechanisms/er-associated-degradation)
• [Protein Quality Control](/mechanisms/protein-quality-control)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Unfolded Protein Response](/mechanisms/unfolded-protein-response)

See Also

• [Molecular Chaperones](/mechanisms/molecular-chaperones)
• [Proteostasis](/mechanisms/proteostasis)
• [ER Stress in Neurodegeneration](/mechanisms/er-stress-neurodegeneration)
• [Hsp70 Chaperone System](/mechanisms/hsp70-chaperone-system)
• [Aggresome Formation](/mechanisms/aggresome-formation)

External Links

• [UniProt: Q9Y2H1](https://www.uniprot.org/uniprot/Q9Y2H1)
• [AlphaFold: Q9Y2H1](https://alphafold.ebi.ac.uk/entry/Q9Y2H1)
• [GeneCards: DNAJC14](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DNAJC14)
• [OMIM: 607394](https://omim.org/entry/607394)
• [HGNC: 19996](https://www.genenames.org/data/hgnc_data.php?hgnc_id=19996)

References